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Asthma-like symptoms like wheezing and dyspnea affect 1 in every 3 preschool children.
An easily available biomarker that predicts later asthma or unfavorable lung growth in
these children may be helpful in targeting the right child with the right drugs and avoiding
exposure to potentially harmful drugs in others. The fraction of exhaled nitric oxide (FeNO)
has been suggested as a marker of eosinophilic inflammation. FeNO can be measured
in a standardized way from the age of 4 but several methods have been developed to
measure FeNO also in younger children. Several studies have assessed the predictive
value of FeNO in preschool wheezing children for asthma later in life. These studies have
shown that FeNO may be helpful in defining different preschool wheezing phenotypes,
and in assessing the risk of later asthma or impaired lung growth. However, data are
conflicting on the added value over clinical parameters. In two studies in school children,
high FeNO was predictive for asthma development during follow up and also predicted
lower lung function growth. In school children with respiratory symptoms suggestive
of asthma, particularly in atopic children, FeNO has diagnostic value for an asthma
diagnosis, mostly for ruling in asthma. There are not enough data to assess if FeNO
has a predictive value for lung development in school children.
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INTRODUCTION
Asthma is the most prevalent chronic disorder in the western world affecting 5–15% of all school
aged children and most of them have their first respiratory symptoms before they turn 5 (1, 2).
Asthma-like symptoms like wheezing and dyspnea are even more frequent in preschool children
with 1 in every 3 children having at least 1 wheezing episode before the age of 4 (3). Only a minority
of these preschool children will develop asthma later in life and may benefit from early treatment
with controller therapy to prevent symptoms and exacerbations (4). However, some of them, in
particular children with severe wheezing exacerbations during the preschool years, have a lower
lung function already at age 5 or 6 (5, 6). As lung function tracks during life, it is important to
identify children at risk for developing asthma, impaired lung growth, and/or early decline in lung
function as early as possible (7). Although the natural course of asthma cannot be altered by asthma
medications such as the inhaled corticosteroids (ICS), symptoms can be reduced and lung function
possibly maintained while on ICS (8, 9). Therefore, an easily available non-invasive biomarker that
predicts later asthma in preschool children may be helpful in targeting the right child with the right
drugs and avoiding exposure to potentially harmful drugs in others.
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The fraction of exhaled nitric oxide (FeNO), has been
suggested as a non-invasive biomarker of (mostly eosinophilic)
inflammation (10). In atopic asthmatic children, there is a
moderate to goodcorrelation between FeNO and eosinophil
counts in blood, induced sputum or broncho-alveolar lavage
fluid (10–12). In preschool children elevated blood eosinophils
have been associated with the development of later asthma
suggesting that blood esoinophils may be an easy biomarker for
later asthma (13, 14).
FeNO can be measured in a standardized way with an
online single breath technique with constant expiratory flow,
with increasing success rates of 40% at age 4 to almost 100%
at age 10 (15, 16). Unfortunately, in preschool children the
single breath technique is not feasible and alternative techniques
have been developed for FeNO measurement (15). The tidal
breathing oﬄine method, with collection of exhaled air via
a facemask in an appropriate reservoir for later analysis, is
the most simple, is feasible in almost all children and shows
good within-subject reproducibility (17, 18). The disadvantages
of this technique are that expiratory flow is not controlled,
while FeNO is highly flow-dependent, and that contamination
with high concentrations of NO produced in the nasal cavity
cannot be avoided. The latter can be solved by exhaling against
a resistance and with a septum in the facemask, separating
air from the upper and lower airways. A modification of the
online single breath technique is to measure FeNO during
a (raised volume) rapid thoracic compression maneuver at
the end-expiratory plateau phase of the NO profile (19).
This technique requires sedation and highly trained personnel.
Alternatively, in children who do accept a mouthpiece manual
adjustment of the expiratory flow or the use of dynamic
flow restrictors may allow for a single breath, flow-controlled
exhalation (20, 21).
Newer technology with fast-response chemiluminescence
analyzers and flow control devices, may make it feasible to
measure FeNO with a single breath technique in children as
young as 3 years (22). Also, with mathematical algorithms single
breath constant flow values may be derived from tidal breathing
FeNO values (23). For now, the oﬄine tidal breathing technique
with a mask separating mouth and nose seems the most simple
method to measure FeNO in preschool children.
Predicting Asthma With FeNO
Several studies assessed FeNO in preschool children. Higher
FeNO values were found in young children with (recurrent)
wheezing compared to healthy preschool children (19, 24–26),
children with frequent wheezing with high vs. low asthma
predictive index (API) (27, 28) and in children with persistent
wheezing vs. transient wheezing (29). These studies were
mainly cross sectional and compared two groups of children.
Although these studies suggest that FeNO may help to
phenotype young wheezing children, only few studies assessed
the predictive value of FeNO in the preschool years for
later asthma.
In a study in almost 400 children with lower airway symptoms,
Singer et al. measured FeNO oﬄine with a tidal breathing
technique at a mean age of 22 months, and modified the classical
API by including FeNO > 10 ppb as a major criterion and
changing blood eosinophils > 4% from major to minor criterion
(30). At school age, a doctor’s diagnosis of asthma was based on
standardized interviews. Children with asthma at school age had
higher FeNO levels compared to children without asthma at that
age (10.5 vs. 6.2 ppb; P < 0.001). The new API including FeNO
had a positive predictive value of 58% and a negative predictive
value of 78% for later asthma, which was actually comparable to
the classical API.
Caudri et al. studied the predictive value of FeNO, specific IgE
and airway resistance as measured with the interrupter technique
(Rint) in 3–4 year old children with wheezing symptoms (31).
Both FeNO and specific IgE were associated with asthma at 8
years, also after mutual adjustment and adjustment for clinical
history. In other words, FeNO had an additive predictive value
over specific IgE and also over the clinical history (asthmatic
mother, wheezing frequency and eczema). This study showed
that even though FeNO and specific IgE are correlated, FeNO
does not merely reflect atopy.
A cross sectional study from Denmark showed low feasibility
of online single-breath FeNO measurements ranging from 0 to
71% in children of 3 to 6 years old, respectively (32). In this study
FeNO >11.5 ppb had low sensitivity but high specificity (93%)
for an asthma diagnosis.
In unselected newborns FeNO before any respiratory
symptom occurred was not associated with asthma at school
age, suggesting that environmental factors are needed to induce
NO production (33). However, in a longitudinal study in 116
high-risk children with eczema, Chang and co-workers found
increased FeNO levels before any wheezing illness in children
who had asthma and increased airway reactivity at age 5 (34). A
steeper increase in FeNO was seen in children with asthma at age
5 compared to children without asthma at that age, which is in
line with the hypothesis that environmental factors are needed to
induce iNOS and that there might be a window of opportunity in
the preschool years.
In a longitudinal cohort of 42 preschool children (6–24
months old) with recurrent wheezing FeNO≥ 30 ppb as assessed
with a single breath technique during the raised volume rapid
thoracic compression technique had a high predictive value for
persisting wheezing at age 3 (area under the receiver operating
curve, AUC 0.86) (35). This predictive value was better than that
of the API. What is more, FeNO ≥ 30 ppb but also tidal-FENO
≥ 7 ppb was associated with a decline in FEV0.5 and FEF25−75
between inclusion and age 3 years. While using the same single
breath technique, the same group, showed that a 10 ppb increase
in FeNO was associated with a 0.4 z-score decline in FEV0.5,
a 0.4 z-score decline in FEF25−75, and a 0.42 z-score decline
in FEF75 6 months later (36). FeNO also predicted wheezing
exacerbations in the 6 months following measurement (AUC
0.83, 95% CI: 0.69–0.96). However, measuring single breath
FeNO in infants and preschool children is challenging,
requires well-trained personnel and is only feasible in
research settings.
Klaassen et al. assessed if a change in FeNO after 8 weeks of
inhaled corticosteroids in preschool children predicted asthma at
school age but this was not the case (37).
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It is important to realize that cut off values and predictive
values of FeNO may differ between the studies due to different
measurement techniques.
In school children only 2 studies have been published
examining the predictive value of FeNO for the development
of asthma. A study in more than 2,000 asthma-free school
children (aged 7–10 years) assessed if FeNO could predict
asthma development during 3 years follow up. The authors
showed that children in the highest FeNO quartile had more
than a 2-fold increased risk of new-onset asthma compared to
those with the lowest quartile (hazard ratio 2.1, 95% CI 1.3–
3.5). This effect was most notable in children with a negative
parental history of asthma and did not vary with a history of
allergic rhinitis (38). In a smaller study 109 children with allergic
rhinitis (mean age 8.4 years, range 7–13) were followed for 5
years when they were evaluated for an asthma diagnosis (39).
Children with FeNO > 35 ppb at baseline had a higher risk
of developing asthma when compared to children with lower
FeNO values (OR 2.49, P < 0.01) and every 10 ppb increase
above this cutoff doubled the risk of asthma further. Also,
children with FeNO > 35 ppb had a decrease in FEV1 and
FVC while in the children with FeNO < 35 ppb FEV1 and
FVC increased, suggesting less lung growth in children with high
FeNO values.
In summary, the studies mentioned here have shown that
FeNO may be helpful in objectively defining different wheezing
phenotypes in preschool children, and assessing the risk of
asthma or impaired lung growth later in life. Preschool children
with increased FeNO levels have an increased risk of later asthma.
Data are conflicting on the added value over clinical parameters.
In two studies in school children, high FeNO was predictive for
asthma development during follow up and also predicted lower
lung function growth.
FeNO in the Diagnosis of Asthma in School
Children
In children only few studies assessed the value of FeNO
for diagnosing asthma (40–42). Woo et al. included 245
steroid-naïve children with respiratory symptoms suggestive
of asthma. Asthma was diagnosed in 167 of them, based
on symptoms and ≥ 12% bronchodilator response and/or
airway hyperresponsiveness as assessed with methacholine
provocation (40). The negative and positive predictive values
of FeNO at a cutoff of 22 ppb for an asthma diagnosis
were 90.5 and 48.6%, respectively. FeNO performed better
as a diagnostic test in the atopic children (AUC 0.85, 95%
CI 0.79–0.90) if compared to atopic and non-atopic children
all together (AUC 0.76; 95% CI 0.70–0.82). In a study from
Israel in 150 children who were referred with respiratory
symptoms, FeNO, sputum eosinophils and FEV1 were assessed
at baseline. During the following 18 months asthma was
diagnosed based on wheezing exacerbations, bronchodilator
response ≥ 15% and/or FEV1 variability ≥ 15% and/or a
positive bronchoprovocation test (41). FeNO performed similar
as sputum eosinophils for the diagnosis asthma (AUC 0.90 and
0.92, respectively) and better than baseline FEV1. Nineteen ppb
appeared the best cutoff with sensitivity of 80%, specificity of
92%, positive predictive value of 89% and a negative predictive
value of 86%.
A third study that assessed the diagnostic value of FeNO was
performed in 4–8 years old children with asthmatic symptoms.
Children with recent recurrent wheeze were labeled as “probable
asthma” and compared to controls. The analysis of the ROC
showed that FeNO had good power for discriminating between
children with probable asthma and healthy controls, with a
sensitivity of 86% and specificity of 92% at the cut off level of
1.5 SD above predicted. This was better than the predictive value
of lung function and bronchodilator response as assessed with
impulse oscillometry (42).
A real-life retrospective study in 3,612 children with
symptoms suggestive of asthma showed poor predictive value of
FeNO >15.8 ppb for an asthma diagnosis with an area under the
ROC curve of only 0.53 (43).
In an unselected population of 1,602 children, questionnaires,
spirometry with bronchodilator response and FeNO were
assessed. Asthma was defined as symptoms suggestive of asthma
with reported medical diagnosis or evidence of bronchodilator
response. FeNO had poor predictive value (area under the ROC
curve 0.62) (44). This poor predictive value may be explained
by the fact that unselected children were included, in contrast to
most studies that included children with respiratory symptoms.
In general, FeNOhas diagnostic value for an asthma diagnosis,
in particular in children with respiratory symptoms and in atopic
children and mostly ruling in asthma. The National Institute
for Health and Care Excellence (NICE) recommends measuring
FeNO as a diagnostic tool in adults and children who have an
intermediate probability of having asthma and in combination
with other diagnostic options such as spirometry (45). Similarly,
the British Thoracic Society guidelines recommend to
use FeNO (if available) “to find evidence of eosinophilic
inflammation” (46). In contrast, the 2018 GINA guidelines
conclude that FENO has not been established useful for an
asthma diagnosis (4).
FeNO in Predicting Lung Function Decline
Several recent studies showed that high baseline FeNO was
associated with reduced lung function growth in asthmatic
children (47) and accelerated lung function decline in adults
(48, 49). In the pediatric study from China 193 asthmatic
children, mean age 9.7 years (SD 1.9 years) were followed for
5 years (47). One quarter had reduced lung function growth
which was associated with lower baseline spirometry, higher
FeNO and female sex. Also, two single nucleotide polymorphisms
(GSDMB_rs2305480 and IL33_rs1342326) were associated with
longitudinal changes in lung function.
More longitudinal studies in children are needed to assess the
predictive value of FeNO for lung development.
CONCLUSION
In preschool children FeNO may be helpful in objectively
discriminating between different wheezing phenotypes and in
predicting asthma later in life.
Only few studies in school children assessed the diagnostic
value of FeNO for an asthma diagnosis; particularly in atopic
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children with respiratory symptoms, FeNO has a high positive
predictive value for an asthma diagnosis. If FeNO helps to
predict lung function decline or impaired lung growth remains
to be shown.
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